Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on June 14, 2006
J Am Soc Nephrol 17: 2026-2033, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006030262

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006030262v1
17/7/2026    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daudon, M.
Right arrow Articles by Jungers, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daudon, M.
Right arrow Articles by Jungers, P.

Clinical Nephrology

Type 2 Diabetes Increases the Risk for Uric Acid Stones

Michel Daudon*, Olivier Traxer{dagger}, Pierre Conort{ddagger}, Bernard Lacour* and Paul Jungers§

Assistance Publique–Hôpitaux de Paris, * Laboratoire de Biochimie A and § Service de Néphrologie, Hôpital Necker-Enfants Malades, {dagger} Service d’Urologie, Hôpital Tenon, and {ddagger} Service d’Urologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

Address correspondence to: Dr. Michel Daudon, AP-HP, Service de Biochimie A, Hôpital Necker-Enfants Malades, 149, Rue de Sèvres, 75743 Paris Cedex 15, France. Phone: +33-01-44-49-51-18; Fax: +33-01-44-49-51-20; E-mail: michel.daudon{at}nck.aphp.fr

Received for publication March 23, 2006. Accepted for publication April 27, 2006.

An increased prevalence of nephrolithiasis has been reported in patients with diabetes. Because insulin resistance, characteristic of the metabolic syndrome and type 2 diabetes, results in lower urine pH through impaired kidney ammoniagenesis and because a low urine pH is the main factor of uric acid (UA) stone formation, it was hypothesized that type 2 diabetes should favor the formation of UA stones. Therefore, the distribution of the main stone components was analyzed in a series of 2464 calculi from 272 (11%) patients with type 2 diabetes and 2192 without type 2 diabetes. The proportion of UA stones was 35.7% in patients with type 2 diabetes and 11.3% in patients without type 2 diabetes (P < 0.0001). Reciprocally, the proportion of patients with type 2 diabetes was significantly higher among UA than among calcium stone formers (27.8 versus 6.9%; P < 0.0001). Stepwise regression analysis identified type 2 diabetes as the strongest factor that was independently associated with the risk for UA stones (odds ratio 6.9; 95% confidence interval 5.5 to 8.8). The proper influence of type 2 diabetes was the most apparent in women and in patients in the lowest age and body mass index classes. In conclusion, in view of the strong association between type 2 diabetes and UA stone formation, it is proposed that UA nephrolithiasis may be added to the conditions that potentially are associated with insulin resistance. Accordingly, it is suggested that patients with UA stones, especially if overweight, should be screened for the presence of type 2 diabetes or components of the metabolic syndrome.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
I. A. Bobulescu, M. Dubree, J. Zhang, P. McLeroy, and O. W. Moe
Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1315 - F1322.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
N. M. Maalouf, M. A. Cameron, O. W. Moe, B. Adams-Huet, and K. Sakhaee
Low Urine pH: A Novel Feature of the Metabolic Syndrome
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 883 - 888.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP